ES2185111T3 - Diagnostico de trastornos neurodegenerativos. - Google Patents

Diagnostico de trastornos neurodegenerativos.

Info

Publication number
ES2185111T3
ES2185111T3 ES98300342T ES98300342T ES2185111T3 ES 2185111 T3 ES2185111 T3 ES 2185111T3 ES 98300342 T ES98300342 T ES 98300342T ES 98300342 T ES98300342 T ES 98300342T ES 2185111 T3 ES2185111 T3 ES 2185111T3
Authority
ES
Spain
Prior art keywords
diagnosis
neurodegenerative disorders
neuro
sample
particulate material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98300342T
Other languages
English (en)
Inventor
Harash Kumar Narang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotec Global Ltd
Original Assignee
Biotec Global Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Global Ltd filed Critical Biotec Global Ltd
Application granted granted Critical
Publication of ES2185111T3 publication Critical patent/ES2185111T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL METODO DIAGNOSTICO COMPRENDE CONCENTRAR UNA PROTEINA ASOCIADA CON EL TRASTORNO NEURODEGENERATIVO EN UNA MUESTRA DE FLUIDO CORPORAL TOMADA DEL ANIMAL. LA CONCENTRACION SE REALIZA PONIENDO EN CONTACTO LA MUESTRA CON UN MATERIAL SOLIDO, PARTICULADO, NO BOYANTE QUE TIENE VALENCIAS IONICAS LIBRES. ENTONCES SE MONITORIZA LA PROTEINA RESULTANTE ASOCIADA CON EL TRASTORNO NEUROVEGETATIVO CONCENTRADA SOBRE EL MATERIAL PARTICULADO.
ES98300342T 1997-01-18 1998-01-19 Diagnostico de trastornos neurodegenerativos. Expired - Lifetime ES2185111T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701045.8A GB9701045D0 (en) 1997-01-18 1997-01-18 Diagnosis of neuro-degenerative disorders

Publications (1)

Publication Number Publication Date
ES2185111T3 true ES2185111T3 (es) 2003-04-16

Family

ID=10806230

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98300342T Expired - Lifetime ES2185111T3 (es) 1997-01-18 1998-01-19 Diagnostico de trastornos neurodegenerativos.

Country Status (7)

Country Link
EP (1) EP0854364B1 (es)
AT (1) ATE223056T1 (es)
DE (1) DE69807363T2 (es)
DK (1) DK0854364T3 (es)
ES (1) ES2185111T3 (es)
GB (1) GB9701045D0 (es)
PT (1) PT854364E (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69834193T2 (de) * 1997-08-01 2007-04-19 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten
DE69842048D1 (de) 1997-08-01 2011-01-27 Max Planck Gesellschaft Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein-aggregaten
AU755535B2 (en) * 1998-02-06 2002-12-12 Harash Kumar Narang Diagnosis of neuro-degenerative disorders
US7595199B1 (en) 1998-07-31 2009-09-29 Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. Method of detecting amyloid-like fibrils or protein aggregates
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10061200A1 (de) * 2000-12-08 2002-06-27 Niels Wedemeyer Verfahren und Kit zur Diagnose spongiformer Encephalopathien
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
JPH0327349A (ja) * 1989-06-24 1991-02-05 Asahi Optical Co Ltd 蛋白質、ペプチド及びアミノ酸の分離方法
EP0600951A4 (en) * 1991-08-01 1996-10-30 Paul H Voorheis Diagnostic method for alzheimer's disease.
GB9117910D0 (en) * 1991-08-20 1991-10-09 Nat Res Dev Oligonucleotides and their use in an assay
GB2308659B (en) * 1994-11-29 1998-11-18 Mini Agriculture & Fisheries Spongiform encephalopathy detection methods
CA2205228A1 (en) * 1994-11-29 1996-06-06 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty 's Government Of The United Kingdom Of Great Britain And Northern Irelan D Spongiform encephalopathy detection methods

Also Published As

Publication number Publication date
GB9701045D0 (en) 1997-03-05
DK0854364T3 (da) 2002-12-23
ATE223056T1 (de) 2002-09-15
EP0854364A1 (en) 1998-07-22
EP0854364B1 (en) 2002-08-28
DE69807363D1 (de) 2002-10-02
PT854364E (pt) 2003-01-31
DE69807363T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
ES2061873T3 (es) Enriquecimiento y concentracion de proteinas por ultrafiltracion.
DE3685344D1 (de) Vorrichtung zur feststellung von okkultem blut.
DE3675702D1 (de) Vorrichtung zum erfassen von fremden substanzen durch eine trennwand und fahrhilfssystem fuer fahrzeuge oder luftfahrzeuge.
DE3668511D1 (de) Vorrichtung zur ueberwachung des betriebsverhaltens eines fahrzeugs.
ATE366812T1 (de) Neue methode zur erkennung eines stoffes, der die interaktion zwischen einem tnf-liganden und seinem rezeptor auf b-zellen moduliert
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
ES557662A0 (es) Un metodo y su correspondiente dispositivo para la determinacion de anticuerpos en liquidos biologicos.
DE69005069D1 (de) Vorrichtung zur Feststellung des Vorhandenseins von fremden Stoffen.
DE59101912D1 (de) Vorrichtung zur Analyse von Druckkontrollfeldern.
ES2185111T3 (es) Diagnostico de trastornos neurodegenerativos.
DE68914228D1 (de) Vorrichtung für die Trennung von Flüssigkeiten.
ATE384315T1 (de) Vorrichtung zum überwachen von sich bewegenden körpern
DE3769808D1 (de) Vorrichtung zur ueberwachung von okkultem blut.
ATE271603T1 (de) Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden
FR2625321B1 (fr) Reactif pour le diagnostic de staphylococcus aureus par agglutination
PT1105508E (pt) Metodo de purificacao de complexos de biomoleculas ou de proteinas
DE69020987D1 (de) Verfahren und Vorrichtung zur elektrochemischen Analyse und wässerige Lösung zur Durchführung der Analyse.
NO903681D0 (no) Monoklonale antistoffer mot aktiverte ras-proteiner med aminosyremutasjoner i posisjon 13 i proteinet.
CA2286279A1 (en) Diagnosis of neuro-degenerative disorders
ES2097158T3 (es) Ensayo funcional para la determinacion de la actividad de proteina s.
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
ATE73463T1 (de) Monoklonale antikoerper.
DE3767659D1 (de) Verfahren und testelement zum auffinden von zellaesionen.
BR9816079A (pt) Diagnóstico de desordens neuro-degenerativas
DE69431363D1 (de) Sensor zur überwachung der ionenaktivität in biologischen flüssigkeiten